| Literature DB >> 31346658 |
Stephanie Eid1, Kelli M Sas2, Steven F Abcouwer3, Eva L Feldman1, Thomas W Gardner3,4, Subramaniam Pennathur2,4, Patrice E Fort5,6.
Abstract
Diabetes adversely affects multiple organs, including the kidney, eye and nerve, leading to diabetic kidney disease, diabetic retinopathy and diabetic neuropathy, respectively. In both type 1 and type 2 diabetes, tissue damage is organ specific and is secondary to a combination of multiple metabolic insults. Hyperglycaemia, dyslipidaemia and hypertension combine with the duration and type of diabetes to define the distinct pathophysiology underlying diabetic kidney disease, diabetic retinopathy and diabetic neuropathy. Only recently have the commonalities and differences in the metabolic basis of these tissue-specific complications, particularly those involving local and systemic lipids, been systematically examined. This review focuses on recent progress made using preclinical models and human-based approaches towards understanding how bioenergetics and metabolomic profiles contribute to diabetic kidney disease, diabetic retinopathy and diabetic neuropathy. This new understanding of the biology of complication-prone tissues highlights the need for organ-specific interventions in the treatment of diabetic complications.Entities:
Keywords: Diabetes; Diabetic complications; Lipid metabolism; Omics; Review; Specific mechanisms
Mesh:
Year: 2019 PMID: 31346658 PMCID: PMC6679814 DOI: 10.1007/s00125-019-4959-1
Source DB: PubMed Journal: Diabetologia ISSN: 0012-186X Impact factor: 10.122